Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32
This study has been terminated.
First Posted: October 11, 2002
Last Update Posted: August 17, 2012
Information provided by (Responsible Party):
The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after six weeks of treatment in Caucasian and Japanese subjects.
|Open-angle Glaucoma Ocular Hypertension||Drug: IOP Lowering Medications||Phase 4|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Phase 4 Study to Compare Two Different IOP Lowering Medications for the Treatment of Open Angle Glaucoma or Ocular Hypertension in Caucasian and Japanese Subjects C-02-32.|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Alcon Research:
Contacts and Locations
No Contacts or Locations Provided